India can claim with some degree of force to be ‘the pharmacy to the world.’ Not only are Indian medicines consumed in the US and EU, but enterprising Indian companies are increasingly looking towards huge underserved developing markets across the globe.…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Hong Kong, based on in-depth interviews conducted with leaders and pioneers across the value chain, from…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Indonesia, based on in-depth interviews conducted with leaders and pioneers across the value chain, from…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies on Taiwan, based on in-depth interviews conducted with leaders and pioneers across the value chain, from…
This report offers companies, investors, policymakers, and stakeholders crucial insight into five companies at the cutting edge of Taiwan’s biotech industry: PharmaEngine, PharmaEssentia, OBI Pharma, SyneuRx, and TaiGen Biotechnology. The report features in-depth exclusive…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Singapore; a nation that has had to carve out its own niche as a global trade hub and gateway to the Asia-Pacific region to compete globally since declaring independence in 1965. In…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Philippines; one of the most promising pharmaceutical markets in the Asia-Pacific region with a population of over 100 million, an annual GDP growth rate of around 6.5%, and a…
The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into a country already leading the way in Southeast Asia and with the potential to grow further. With a burgeoning middle class…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Philippines; one of the most promising pharmaceutical markets in the Asia-Pacific region with a population of over 100 million, an annual GDP growth rate of around 6.5%, and a…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies on Taiwan, based on in-depth interviews conducted with leaders and pioneers across the value chain, from…